Dóra Karancsiné Menyhárd
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dóra Karancsiné Menyhárd has a total of 123 co-authors. Here are the top co-authors by number of shared publications:
- András Perczel
Laboratory of Structural Chemistry and Biology, Institute of Chemistry, ELTE Eötvös Loránd University, Pázmány Péter Sétány 1/A, 1117 Budapest, Hungary
21 shared publications - Zsolt Fazekas
Laboratory of Structural Chemistry and Biology, Institute of Chemistry, Eötvös Loránd University, Pázmány Péter sétány 1/A, H-1117 Budapest, Hungary
8 shared publications - Márton Gadanecz
Laboratory of Structural Chemistry and Biology, Institute of Chemistry Eötvös Loránd University Pázmány Péter sétány 1/A H-1117 Budapest Hungary
6 shared publications - Gitta Schlosser
MTA-ELTE Lendület (Momentum) Ion Mobility Mass Spectrometry Research Group and Department of Analytical Chemistry, Institute of Chemistry, ELTE Eötvös Loránd University, Pázmány Péter sétány 1/A, H-1117 Budapest, Hungary
5 shared publications - Gyorgy Miklos Keseru
Medicinal Chemistry Research Group and Drug Innovation Centre, HUN-REN Research Centre for Natural Sciences, Magyar tudósok krt. 2, 1117 Budapest, Hungary
5 shared publications Zoltán Orgován
Medicinal Chemistry Research Group HUN-REN Research Centre for Natural Sciences Magyar Tudósok Körútja 2 H-1117 Budapest Hungary
5 shared publications
Latest Publications
- Open Access
- 8 November 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (11) , 1773
Synthesis, Antiproliferative Activity and In Silico Conformational Analysis of Triazole-Tethered Vindoline–Chalcone Hybrids Targeting the Vinblastine Site of Microtubules
Background/Objectives: Cancer is one of the leading causes of mortality worldwide. However, due to limitations in clinical treatment of malignancies, there is a continuous need for the development of more potent novel drugs with enhanced activity and selectivity towards tumours. Methods: In this context, we synthesised a focused library of chalcone–vindoline hybrids incorporating a 1,4-disubstituted 1,2,3-triazole linker using a modular strategy combining sequential Sonogashira coupling and CuAAC reactions. The same synthetic route afforded a zidovudine-derived vindoline hybrid, which served as a negative control to underscore the pivotal role of the chalcone moiety in mediating antiproliferative activity. To elucidate the contribution of the vindoline scaffold, two corresponding aryl-substituted chalcone analogues were also prepared. The synthesised hybrids and the reference compounds were evaluated against a panel of human adherent cancer cell lines (HeLa, SiHa, MCF-7, MDA-MB-231 and A2780) and non-malignant NIH/3T3 fibroblasts. Results: Vindoline hybrids incorporating trimethoxyphenyl chalcone moieties exhibited outstanding potency on all the cancer cell lines tested. By contrast, hybrids containing monomethoxy-substituted chalcone moieties with moderately reduced activity against malignant cells displayed a certain degree of cancer selectivity. A ferrocene-containing hybrid and the vindoline-free chalcones exhibited markedly lower antiproliferative activity, whereas another ferrocene hybrid featuring an alternative enone configuration and the zidovudine-derived vindoline hybrid were inactive. Molecular modelling results indicate that the vindoline hybrids might bind to the inter-dimer vinca crevice of tubulin oligomers and that the two segments exert a mutually stabilising effect on the binding of the other. Conclusion: Collectively, these findings provide a framework for future rational optimisation of this promising class of anticancer agents.
- 8 November 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (11) , 1773
Open AccessSynthesis, Antiproliferative Activity and In Silico Conformational Analysis of Triazole-Tethered Vindoline–Chalcone Hybrids Targeting the Vinblastine Site of Microtubules
Background/Objectives: Cancer is one of the leading causes of mortality worldwide. However, due to limitations in clinical treatment of malignancies, there is a continuous need for the development of more potent novel drugs with enhanced activity and selectivity towards tumours. Methods: In this context, we synthesised a focused library of chalcone–vindoline hybrids incorporating a 1,4-disubstituted 1,2,3-triazole linker using a modular strategy combining sequential Sonogashira coupling and CuAAC reactions. The same synthetic route afforded a zidovudine-derived vindoline hybrid, which served as a negative control to underscore the pivotal role of the chalcone moiety in mediating antiproliferative activity. To elucidate the contribution of the vindoline scaffold, two corresponding aryl-substituted chalcone analogues were also prepared. The synthesised hybrids and the reference compounds were evaluated against a panel of human adherent cancer cell lines (HeLa, SiHa, MCF-7, MDA-MB-231 and A2780) and non-malignant NIH/3T3 fibroblasts. Results: Vindoline hybrids incorporating trimethoxyphenyl chalcone moieties exhibited outstanding potency on all the cancer cell lines tested. By contrast, hybrids containing monomethoxy-substituted chalcone moieties with moderately reduced activity against malignant cells displayed a certain degree of cancer selectivity. A ferrocene-containing hybrid and the vindoline-free chalcones exhibited markedly lower antiproliferative activity, whereas another ferrocene hybrid featuring an alternative enone configuration and the zidovudine-derived vindoline hybrid were inactive. Molecular modelling results indicate that the vindoline hybrids might bind to the inter-dimer vinca crevice of tubulin oligomers and that the two segments exert a mutually stabilising effect on the binding of the other. Conclusion: Collectively, these findings provide a framework for future rational optimisation of this promising class of anticancer agents.
- Open Access
- 2 October 2026
- Published by MDPI AG in Preprints.org
Synthesis, Antiproliferative Activity and In Silico Docking Analysis of Tubulin-Polymerase-Targeting Triazole-Tethered Vindoline-Chalcone Hybrids
In the frame of our ongoing research on multitarget alkaloid-derived anticancer agents, relying on a modular synthetic strategy terminated by well-established sequential Sonogashira and CuAAC protocols, we synthesized a systematic selection of chalcone-vindoline hybrids incorporating 1,4-disubstituted 1,2,3-triazole as a linker. The use of the same synthetic approach led to the construction of a zidovudine-derived vindoline hybrid, which served as a negative control highlighting the essential contribution of the chalcone moiety to the antiproliferative activity. Two analogous aryl-substituted chalcone hybrids 14a,b were also prepared to assess the contribution of the vindoline fragment to the desired effect. The targeted hybrids and the references were evaluated for their antiproliferative activity against a panel of human adherent gynecological cancer cell lines (HeLa, SiHa, MCF-7, MDA-MB-231 and A2780) as well as on non-malignant fibroblasts (NIH/3T3). Vindoline hybrids 10a and 10i comprising 3,4,5- and 1,4,6-trimethoxyphenyl-substituted chalcone fragments, respectively, displayed substantial activity, featuring IC50 values lower than 0.4 µM on all the investigated cancer cell lines. On the other hand, hybrids 10c–e containing monomethoxy-substituted chalcones, also featuring submicromolar IC50 values on malignant cells, showed moderately lower activities against non-malignant fibroblasts (NIH/3T3), indicating a certain degree of cancer selectivity. The related ferrocene-derived hybrid (10i) and vindoline-free chalcones 14a,b were identified as antiproliferative agents with significantly decreased efficiency, while the ferrocene hybrid comprising an alternative enone sequence in the chalcone residue (11) as well as the zidovudine-derived vindoline hybrid 12 were inactive. Modeling results indicate that the vindoline hybrids bind to the inter-dimer vinca crevice of tubulin oligomers and confirm that the two segments exert a mutually stabilizing effect on the binding of the other, providing a framework for future structure optimization.
- 2 October 2026
- Published by MDPI AG in Preprints.org
Open AccessSynthesis, Antiproliferative Activity and In Silico Docking Analysis of Tubulin-Polymerase-Targeting Triazole-Tethered Vindoline-Chalcone Hybrids
In the frame of our ongoing research on multitarget alkaloid-derived anticancer agents, relying on a modular synthetic strategy terminated by well-established sequential Sonogashira and CuAAC protocols, we synthesized a systematic selection of chalcone-vindoline hybrids incorporating 1,4-disubstituted 1,2,3-triazole as a linker. The use of the same synthetic approach led to the construction of a zidovudine-derived vindoline hybrid, which served as a negative control highlighting the essential contribution of the chalcone moiety to the antiproliferative activity. Two analogous aryl-substituted chalcone hybrids 14a,b were also prepared to assess the contribution of the vindoline fragment to the desired effect. The targeted hybrids and the references were evaluated for their antiproliferative activity against a panel of human adherent gynecological cancer cell lines (HeLa, SiHa, MCF-7, MDA-MB-231 and A2780) as well as on non-malignant fibroblasts (NIH/3T3). Vindoline hybrids 10a and 10i comprising 3,4,5- and 1,4,6-trimethoxyphenyl-substituted chalcone fragments, respectively, displayed substantial activity, featuring IC50 values lower than 0.4 µM on all the investigated cancer cell lines. On the other hand, hybrids 10c–e containing monomethoxy-substituted chalcones, also featuring submicromolar IC50 values on malignant cells, showed moderately lower activities against non-malignant fibroblasts (NIH/3T3), indicating a certain degree of cancer selectivity. The related ferrocene-derived hybrid (10i) and vindoline-free chalcones 14a,b were identified as antiproliferative agents with significantly decreased efficiency, while the ferrocene hybrid comprising an alternative enone sequence in the chalcone residue (11) as well as the zidovudine-derived vindoline hybrid 12 were inactive. Modeling results indicate that the vindoline hybrids bind to the inter-dimer vinca crevice of tubulin oligomers and confirm that the two segments exert a mutually stabilizing effect on the binding of the other, providing a framework for future structure optimization.
- Open Access
Hybrid Tetramers of Wild-Type and Amyloidogenic H88R Transthyretin Challenge the Monomer Paradigm
Hereditary transthyretin amyloidosis (ATTRv) is driven by mutations that destabilize the native tetrameric transthyretin (TTR), promoting monomer formation and amyloid aggregation. The H88R variant has been considered fully monomeric, yet its behavior in heterozygous patients has remained unclear. Here, we demonstrate that H88R TTR can form hybrid tetramers with wild-type chains, both in vitro and in patient sera. We considered all possible tetramers, along with various trimer and dimer constructions, and found that the stability of hybrid tetramers containing one or two mutant chains is not significantly reduced in comparison with of the wild-type tetramer, suggesting a practically unhindered entry for H88R TTR monomers into such hybrid tetrameric assemblies, facilitating their secretion. Mass spectrometry confirms incorporation of H88R chains into tetramers in vitro, and show that the H88R TTR variant is present in the serum of carriers albeit in low concentration. We propose that the scarcity of this variant is the result of its retention in the endoplasmic reticulum and present a model for the association of H88R TTR with the endoplasmic reticule chaperone Binding immunoglobulin Protein (BiP). These findings revise the current monomeric view of H88R TTR, with direct implications for the efficacy of tetramer-stabilizing therapeutics. Our results highlight a delicate balance between cellular retention and hybridization, informing mechanistic understanding and treatment strategies in heterozygous ATTRv patients.
Open AccessHybrid Tetramers of Wild-Type and Amyloidogenic H88R Transthyretin Challenge the Monomer Paradigm
Hereditary transthyretin amyloidosis (ATTRv) is driven by mutations that destabilize the native tetrameric transthyretin (TTR), promoting monomer formation and amyloid aggregation. The H88R variant has been considered fully monomeric, yet its behavior in heterozygous patients has remained unclear. Here, we demonstrate that H88R TTR can form hybrid tetramers with wild-type chains, both in vitro and in patient sera. We considered all possible tetramers, along with various trimer and dimer constructions, and found that the stability of hybrid tetramers containing one or two mutant chains is not significantly reduced in comparison with of the wild-type tetramer, suggesting a practically unhindered entry for H88R TTR monomers into such hybrid tetrameric assemblies, facilitating their secretion. Mass spectrometry confirms incorporation of H88R chains into tetramers in vitro, and show that the H88R TTR variant is present in the serum of carriers albeit in low concentration. We propose that the scarcity of this variant is the result of its retention in the endoplasmic reticulum and present a model for the association of H88R TTR with the endoplasmic reticule chaperone Binding immunoglobulin Protein (BiP). These findings revise the current monomeric view of H88R TTR, with direct implications for the efficacy of tetramer-stabilizing therapeutics. Our results highlight a delicate balance between cellular retention and hybridization, informing mechanistic understanding and treatment strategies in heterozygous ATTRv patients.
- Open Access
- 14 April 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (16)
Podocin oligomers regulate the ordering of nephrin chains, providing the molecular basis of NPHS2 interallelic interactions
The most frequent causative genes in podocytopathies are NPHS1 and NPHS2 that encode the main slit diaphragm components nephrin and podocin, respectively. The significance of the nephrin–podocin interaction has remained elusive. The NPHS2 R229Q variant is unique in human genetics as it is only pathogenic when trans -associated to specific 3’ variants causing R229Q podocin to form distorted heterooligomers. To examine the effect of podocin on the distance between nephrin molecules, nephrin constructs labeled with YPet or mCherry/mRuby were transitionally coexpressed in HEK-293 cells. We assessed the nephrin–nephrin distance based on the Förster Resonance Energy Transfer (FRET) efficiency between YPet and mCherry/mRuby in living cells. Podocin markedly increased the FRET efficiency between nephrin molecules, reflecting reduced and ordered nephrin–nephrin distances. Its effect was abolished by pathogenic podocin variants. Pathogenic R229Q heterooligomers exhibited increased FRET efficiency between their PHB domains that correlated with a larger nephrin–nephrin distance, thereby explaining the associated mild phenotype. The effect of pathogenic and benign R229Q heterooligomers separated sharply in their effect on nephrin–nephrin spacing ( P = 1.19E-33). Based on an intermediate effect on the nephrin–nephrin distance and five families with late-onset FSGS, we reconsider the R229Q-R286Tfs*17 association as pathogenic, but via a mechanism different from other R229Q associations and with incomplete penetrance. In conclusion, podocin provides regularly spaced intracellular anchor points for nephrin chains. Podocin homo-oligomerization affects the nephrin–nephrin spacing, thereby providing an explanation for albuminuria in patients with podocin dysfunction and for the interallelic interactions of R229Q.
- 14 April 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (16)
Open AccessPodocin oligomers regulate the ordering of nephrin chains, providing the molecular basis of NPHS2 interallelic interactions
The most frequent causative genes in podocytopathies are NPHS1 and NPHS2 that encode the main slit diaphragm components nephrin and podocin, respectively. The significance of the nephrin–podocin interaction has remained elusive. The NPHS2 R229Q variant is unique in human genetics as it is only pathogenic when trans -associated to specific 3’ variants causing R229Q podocin to form distorted heterooligomers. To examine the effect of podocin on the distance between nephrin molecules, nephrin constructs labeled with YPet or mCherry/mRuby were transitionally coexpressed in HEK-293 cells. We assessed the nephrin–nephrin distance based on the Förster Resonance Energy Transfer (FRET) efficiency between YPet and mCherry/mRuby in living cells. Podocin markedly increased the FRET efficiency between nephrin molecules, reflecting reduced and ordered nephrin–nephrin distances. Its effect was abolished by pathogenic podocin variants. Pathogenic R229Q heterooligomers exhibited increased FRET efficiency between their PHB domains that correlated with a larger nephrin–nephrin distance, thereby explaining the associated mild phenotype. The effect of pathogenic and benign R229Q heterooligomers separated sharply in their effect on nephrin–nephrin spacing ( P = 1.19E-33). Based on an intermediate effect on the nephrin–nephrin distance and five families with late-onset FSGS, we reconsider the R229Q-R286Tfs*17 association as pathogenic, but via a mechanism different from other R229Q associations and with incomplete penetrance. In conclusion, podocin provides regularly spaced intracellular anchor points for nephrin chains. Podocin homo-oligomerization affects the nephrin–nephrin spacing, thereby providing an explanation for albuminuria in patients with podocin dysfunction and for the interallelic interactions of R229Q.
- 13 April 2026
- Published by AIP Publishing in The Journal of Chemical Physics
- Vol. 164 (14)
Amide isomerization pathways II: Tracing geometrical prerequisites of acid-catalyzed amide cis – trans isomerization in globular proteins
Although the ribosome primarily synthesizes peptide bonds in a trans conformation, native proteins contain cis amide bonds despite the high activation energy required for spontaneous cis–trans isomerization. We recently proposed a non-enzyme-catalyzed reaction pathway in which a nearby Asp/Glu carboxyl side chain, assisted by one or more water molecules, facilitates the O-protonation of the amide bond, whose proton is subsequently transferred to Namide, eliminating the energy barrier for C–N bond rotation and enabling isomerization. In this study, we performed molecular dynamics simulations on cyclase FamC1, a protein containing a cis peptide bond adjacent to an Asp side chain. Our analysis identified favorable orientations of the carboxyl side chain and surrounding water molecules, satisfying the geometric criteria for the key steps of the isomerization mechanism. Statistical analysis of PDB structures revealed that a carboxyl group is frequently found near Xxx–nonPro peptide bonds, supporting the feasibility of this cis–trans isomerization pathway.
- 13 April 2026
- Published by AIP Publishing in The Journal of Chemical Physics
- Vol. 164 (14)
Amide isomerization pathways II: Tracing geometrical prerequisites of acid-catalyzed amide cis – trans isomerization in globular proteins
Although the ribosome primarily synthesizes peptide bonds in a trans conformation, native proteins contain cis amide bonds despite the high activation energy required for spontaneous cis–trans isomerization. We recently proposed a non-enzyme-catalyzed reaction pathway in which a nearby Asp/Glu carboxyl side chain, assisted by one or more water molecules, facilitates the O-protonation of the amide bond, whose proton is subsequently transferred to Namide, eliminating the energy barrier for C–N bond rotation and enabling isomerization. In this study, we performed molecular dynamics simulations on cyclase FamC1, a protein containing a cis peptide bond adjacent to an Asp side chain. Our analysis identified favorable orientations of the carboxyl side chain and surrounding water molecules, satisfying the geometric criteria for the key steps of the isomerization mechanism. Statistical analysis of PDB structures revealed that a carboxyl group is frequently found near Xxx–nonPro peptide bonds, supporting the feasibility of this cis–trans isomerization pathway.
- Open Access
- 14 March 2026
- Published by Wiley in The FEBS Journal
Investigating transthyretin variants H88R and I107V in amyloid priming: From destabilization to complete dissociation
The destabilization of transthyretin (TTR) tetramers underlies the pathogenesis of ATTR amyloidosis, a disease manifesting in form of toxic amyloid deposits. Here we investigate two clinically relevant TTR variants, H88R and I107V, found among ATTR patients in the Carpathian Basin. While the I107V mutation exerts only a mild effect on tetramer assembly and monomer stability, it decreases the denaturation midpoint and enhances aggregation propensity at physiological pH, against both wild‐type and monomeric TTR (MTTR) backgrounds. Structural analysis revealed that the absence of the methyl group of residue 107 perturbs the hydrophobic trapping of F87 across the primary tetramerization interface. We also found that the far more disruptive H88R mutation that fully abolishes tetramer formation and yields a highly amyloidogenic monomer also acts through the disarray of the F87‐centered inter‐chain contact. Its equilibrium ensemble includes unfolded components and displays reduced denaturation entropy, traits suggestive of a primed aggregation‐prone state. Simulations reveal that the H88R mutation leads to the partial disordering of the EF helix/loop, which in wild‐type TTR participates in a Trp‐cage‐like architecture (centered on W79) shielding the hydrophobic core of the monomeric form. Our results suggest that the H88R variant may serve as a more physiologically relevant model of aggregation‐prone TTR than the widely used MTTR double mutant, which does not show amyloidogenic propensity at physiological pH. Based on their physicochemical properties and position with respect to the determined interaction loci, we offer explanation for the phenotypic presentation of D18G, A25T, and Y114H and H88R monomerizing mutations.
- 14 March 2026
- Published by Wiley in The FEBS Journal
Open AccessInvestigating transthyretin variants H88R and I107V in amyloid priming: From destabilization to complete dissociation
The destabilization of transthyretin (TTR) tetramers underlies the pathogenesis of ATTR amyloidosis, a disease manifesting in form of toxic amyloid deposits. Here we investigate two clinically relevant TTR variants, H88R and I107V, found among ATTR patients in the Carpathian Basin. While the I107V mutation exerts only a mild effect on tetramer assembly and monomer stability, it decreases the denaturation midpoint and enhances aggregation propensity at physiological pH, against both wild‐type and monomeric TTR (MTTR) backgrounds. Structural analysis revealed that the absence of the methyl group of residue 107 perturbs the hydrophobic trapping of F87 across the primary tetramerization interface. We also found that the far more disruptive H88R mutation that fully abolishes tetramer formation and yields a highly amyloidogenic monomer also acts through the disarray of the F87‐centered inter‐chain contact. Its equilibrium ensemble includes unfolded components and displays reduced denaturation entropy, traits suggestive of a primed aggregation‐prone state. Simulations reveal that the H88R mutation leads to the partial disordering of the EF helix/loop, which in wild‐type TTR participates in a Trp‐cage‐like architecture (centered on W79) shielding the hydrophobic core of the monomeric form. Our results suggest that the H88R variant may serve as a more physiologically relevant model of aggregation‐prone TTR than the widely used MTTR double mutant, which does not show amyloidogenic propensity at physiological pH. Based on their physicochemical properties and position with respect to the determined interaction loci, we offer explanation for the phenotypic presentation of D18G, A25T, and Y114H and H88R monomerizing mutations.
- Open Access
- 16 February 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 66 (5) , 2844-2856
Improving Protein Structure Determination by Integrating Ensemble-Driven Molecular Dynamics with Chemical Shift-Based Restraints
We present a protocol for nuclear magnetic resonance (NMR) chemical shift-based structure determination that employs ensemble-driven molecular dynamics (EDMD) for structure refinement. Here, specifically, Chemical-Shift-Rosetta (CS-Rosetta) was applied, followed by EDMD. EDMD eliminates the need to predict chemical shifts at every molecular dynamics (MD) step by defining continuous, differentiable potential energy functions (PEFs) based on dihedral angle distributions from CS-Rosetta models while incorporating the measurement temperature. This yielded a thermodynamically realistic, experiment-based custom force field for each studied system. We benchmarked EDMD against 5 proteins (13.1-19.2 kDa), focusing on systems with nonprotein components and demonstrated its consistent improvement of backbone root-mean-square deviation (RMSD) relative to known reference structures over the original CS-Rosetta ensemble. Moreover, EDMD enhanced the fulfillment of NOE-derived (nuclear Overhauser effect) distance restraints compared to the results of CS-Rosetta and unrestrained MD simulations. EDMD also improved NOE-RASREC-Rosetta (resolution-adapted structural recombination Rosetta protocol supplemented with NOE-based distance restraints) models and maintained the correct protein-ligand conformations. This approach provides an opportunity to refine nonconverged CS-Rosetta structure calculations, where the results would not be interpretable otherwise. EDMD can be generalized to any ensemble with scoring information, enabling refined exploration of the φ/ψ phase space and accurate reinsertion of nonprotein moieties.
- 16 February 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 66 (5) , 2844-2856
Open AccessImproving Protein Structure Determination by Integrating Ensemble-Driven Molecular Dynamics with Chemical Shift-Based Restraints
We present a protocol for nuclear magnetic resonance (NMR) chemical shift-based structure determination that employs ensemble-driven molecular dynamics (EDMD) for structure refinement. Here, specifically, Chemical-Shift-Rosetta (CS-Rosetta) was applied, followed by EDMD. EDMD eliminates the need to predict chemical shifts at every molecular dynamics (MD) step by defining continuous, differentiable potential energy functions (PEFs) based on dihedral angle distributions from CS-Rosetta models while incorporating the measurement temperature. This yielded a thermodynamically realistic, experiment-based custom force field for each studied system. We benchmarked EDMD against 5 proteins (13.1-19.2 kDa), focusing on systems with nonprotein components and demonstrated its consistent improvement of backbone root-mean-square deviation (RMSD) relative to known reference structures over the original CS-Rosetta ensemble. Moreover, EDMD enhanced the fulfillment of NOE-derived (nuclear Overhauser effect) distance restraints compared to the results of CS-Rosetta and unrestrained MD simulations. EDMD also improved NOE-RASREC-Rosetta (resolution-adapted structural recombination Rosetta protocol supplemented with NOE-based distance restraints) models and maintained the correct protein-ligand conformations. This approach provides an opportunity to refine nonconverged CS-Rosetta structure calculations, where the results would not be interpretable otherwise. EDMD can be generalized to any ensemble with scoring information, enabling refined exploration of the φ/ψ phase space and accurate reinsertion of nonprotein moieties.
- Open Access
- 24 January 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Physiologically relevant forms of Tc- and Re-pyrophosphate radioactive tracers and the basis of their transthyretin amyloid sensitivity
$${^{99\text {m}}}$$ Technetium Pyrophosphate ( $${^{99\text {m}}}$$ Tc-PYP(Sn)) is a commonly used radioactive tracer, with a long history of use in diagnosing bone-related diseases and a newfound purpose in differentiating ATTR and AL amyloidoses. Despite its ubiquity, basic aspects like its composition and structure are as of yet undetermined, and its method of binding to ATTR amyloid fibrils is likewise hitherto unknown. This complicates the diagnostic process, as it introduces inexplicable losses of sensitivity in some ATTR and AL variants. In this paper we report the results of our comprehensive investigation into the physiologically active structure of Tc-PYP and its closely related, but experimentally more approachable counterpart, Re-PYP, built on a robust theoretical basis and backed up by multiple spectroscopic methods (focusing on the rhenium analogue). We conclude that the Re/Tc-PYP tracers possess a flexible geometry, but ultimately appear as octahedral Re(IV)/Tc(IV) diaqua dipyrophosphate complexes under physiological conditions, and predict that this structure is the reason for the high affinity of $$\phantom{0}^{99m}$$ Tc-PYP for certain amyloids.- 24 January 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessPhysiologically relevant forms of Tc- and Re-pyrophosphate radioactive tracers and the basis of their transthyretin amyloid sensitivity
$${^{99\text {m}}}$$ Technetium Pyrophosphate ( $${^{99\text {m}}}$$ Tc-PYP(Sn)) is a commonly used radioactive tracer, with a long history of use in diagnosing bone-related diseases and a newfound purpose in differentiating ATTR and AL amyloidoses. Despite its ubiquity, basic aspects like its composition and structure are as of yet undetermined, and its method of binding to ATTR amyloid fibrils is likewise hitherto unknown. This complicates the diagnostic process, as it introduces inexplicable losses of sensitivity in some ATTR and AL variants. In this paper we report the results of our comprehensive investigation into the physiologically active structure of Tc-PYP and its closely related, but experimentally more approachable counterpart, Re-PYP, built on a robust theoretical basis and backed up by multiple spectroscopic methods (focusing on the rhenium analogue). We conclude that the Re/Tc-PYP tracers possess a flexible geometry, but ultimately appear as octahedral Re(IV)/Tc(IV) diaqua dipyrophosphate complexes under physiological conditions, and predict that this structure is the reason for the high affinity of $$\phantom{0}^{99m}$$ Tc-PYP for certain amyloids. - Open Access
- 11 October 2025
- Published by Wiley in Protein Science
- Vol. 34 (11) , e70320
Ligand binding Pro ‐miscuity of acylpeptide hydrolase, structural analysis of a detoxifying serine hydrolase
Acylpeptide hydrolase (APEH) or acylaminoacyl‐peptidase (AAP) is a serine hydrolase that regulates protein metabolism. It can also bind to and process unusual substrates, acting as a detoxifier. To better understand its promiscuous specificity, we determined the cryo‐EM structures of mammalian APEH complexed with classical serine protease partners: a chloromethyl‐ketone (CMK) inhibitor, an organophosphate (OP) pesticide (dichlorvos), and benzenesulfonyl‐fluoride. Since CMK derivatives of N ‐acetylated peptides were suggested to induce apoptosis by inhibiting APEH, while OP complexes may serve as biomarkers of OP exposure and are linked to cognitive enhancement, these complexes carry physiological significance. We identified a unique strand‐breaker Pro residue in the hydrolase domain, which relaxes the active site into a partially inactivated but more spacious conformation, transforming the classical serine protease apparatus into a versatile yet potent hydrolysis center with broad specificity, distinguishing the mammalian enzyme not only from other APEHs but also from serine α/β hydrolases sharing essentially the same fold.
- 11 October 2025
- Published by Wiley in Protein Science
- Vol. 34 (11) , e70320
Open AccessLigand binding Pro ‐miscuity of acylpeptide hydrolase, structural analysis of a detoxifying serine hydrolase
Acylpeptide hydrolase (APEH) or acylaminoacyl‐peptidase (AAP) is a serine hydrolase that regulates protein metabolism. It can also bind to and process unusual substrates, acting as a detoxifier. To better understand its promiscuous specificity, we determined the cryo‐EM structures of mammalian APEH complexed with classical serine protease partners: a chloromethyl‐ketone (CMK) inhibitor, an organophosphate (OP) pesticide (dichlorvos), and benzenesulfonyl‐fluoride. Since CMK derivatives of N ‐acetylated peptides were suggested to induce apoptosis by inhibiting APEH, while OP complexes may serve as biomarkers of OP exposure and are linked to cognitive enhancement, these complexes carry physiological significance. We identified a unique strand‐breaker Pro residue in the hydrolase domain, which relaxes the active site into a partially inactivated but more spacious conformation, transforming the classical serine protease apparatus into a versatile yet potent hydrolysis center with broad specificity, distinguishing the mammalian enzyme not only from other APEHs but also from serine α/β hydrolases sharing essentially the same fold.
- 19 November 2024
- Published by Wiley in Angewandte Chemie
- Vol. 137 (2)
Rücktitelbild: Target‐Templated Construction of Functional Proteomimetics Using Photo‐Foldamer Libraries (Angew. Chem. 2/2025)
- 19 November 2024
- Published by Wiley in Angewandte Chemie
- Vol. 137 (2)
Rücktitelbild: Target‐Templated Construction of Functional Proteomimetics Using Photo‐Foldamer Libraries (Angew. Chem. 2/2025)